Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation

被引：0
|
作者：
Yingxue Lu
Xiaojing Ma
Jie Pan
Rongqiang Ma
Yujie Jiang
机构：
[1] Shandong Provincial Hospital Affiliated to Shandong First Medical University,Department of Cardiology
[2] Shandong Provincial Hospital Affiliated to Shandong First Medical University,Department of Hematology
[3] Shandong Provincial Hospital Affiliated to Shandong First Medical University,undefined
来源：
Lipids in Health and Disease | / 21卷
关键词：
Allogeneic hematopoietic stem cell transplantation; Dyslipidemia; Graft-versus-host disease; Statins; Proprotein convertase subtilisin/Kexin type 9 (PCSK9);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Dyslipidemia is one of the complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT), and it is often underestimated and undertreated. Dyslipidemia in allo-HSCT recipients has been confirmed to be associated with endocrine dysfunction, acute and chronic graft-versus-host disease (aGVHD and cGVHD), immunosuppressive agent application, etc. However, few studies have illustrated the accurate molecular signaling pathways involved in dyslipidemia, and there are no standard guidelines for dyslipidemia management after HSCT. This review will discuss the pathogenesis of dyslipidemia, especially the association with aGVHD and/or cGVHD. Comprehensive treatment methods for dyslipidemia after HSCT will also be summarized.
引用
收藏
相关论文
共 50 条
  • [21] Bronchial Disorders After Allogeneic Hematopoietic Stem Cell Transplantation
    Bergeron, A.
    Godet, C.
    Chevret, S.
    Lorillon, G.
    de Latour, R. Peffault
    Robin, M.
    Ribaud, P.
    Socie, G.
    Tazi, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [22] Diabetes Mellitus after Allogeneic Hematopoietic Stem Cell Transplantation
    Wedrychowicz, Anna
    Ciechanowska, Marta
    Stelmach, Malgorzata
    Starzyk, Jerzy
    HORMONE RESEARCH IN PAEDIATRICS, 2013, 79 (01): : 44 - 50
  • [23] Bullous pemphigoid after allogeneic hematopoietic stem cell transplantation
    Kato, Keisuke
    Koike, Kazutoshi
    Kobayashi, Chie
    Iijima, Shigeruko
    Hashimoto, Takashi
    Tsuchida, Masahiro
    PEDIATRICS INTERNATIONAL, 2015, 57 (03) : 480 - 483
  • [24] Graft failure after allogeneic hematopoietic stem cell transplantation
    Ozdemir, Zehra Narli
    Bozdag, Sinem Civriz
    TRANSFUSION AND APHERESIS SCIENCE, 2018, 57 (02) : 163 - 167
  • [25] ABO antibodies after allogeneic hematopoietic stem cell transplantation
    Stussi, G
    Huggel, K
    Schanz, U
    Halter, J
    Passweg, J
    Gratwohl, A
    Seebach, JD
    BONE MARROW TRANSPLANTATION, 2003, 31 : S114 - S114
  • [26] Immune Reconstitutional after Allogeneic Hematopoietic Stem Cell Transplantation
    Ogonek, Justyna
    Juric, Mateja Kralj
    Ghimire, Sakhila
    Varanasi, Pavankumar Reddy
    Holler, Ernst
    Greinix, Hildegard
    Weissinger, Eva
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [27] Visceral leishmaniasis after allogeneic hematopoietic stem cell transplantation
    Agteresch, H. J.
    Veer, M. B. van 't
    Cornelissen, J. J.
    Sluiters, J. F.
    BONE MARROW TRANSPLANTATION, 2007, 40 (04) : 391 - 393
  • [28] Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation
    Williams, Kirsten M.
    Chien, Jason W.
    Gladwin, Mark T.
    Pavletic, Steven Z.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (03): : 306 - 314
  • [29] Peliosis hepatis after allogeneic hematopoietic stem cell transplantation
    Rerolle, L.
    Salmon, A.
    Clement, L.
    Morali, A.
    Chastagner, P.
    REVUE D ONCOLOGIE HEMATOLOGIE PEDIATRIQUE, 2013, 1 (02): : 98 - 100
  • [30] Cerebral toxoplasmosis after allogeneic hematopoietic stem cell transplantation
    Abdullayev, E.
    Abdullayev, E.
    Fuhrmann, S.
    Eimermacher, C.
    Glass, B.
    LEUKEMIA RESEARCH, 2018, 73 : S57 - S58
12345